Alfonso Varela‐Román

1.8k total citations
67 papers, 1.2k citations indexed

About

Alfonso Varela‐Román is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Nephrology. According to data from OpenAlex, Alfonso Varela‐Román has authored 67 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Cardiology and Cardiovascular Medicine, 12 papers in Molecular Biology and 11 papers in Nephrology. Recurrent topics in Alfonso Varela‐Román's work include Heart Failure Treatment and Management (33 papers), Cardiovascular Function and Risk Factors (30 papers) and Cardiac pacing and defibrillation studies (14 papers). Alfonso Varela‐Román is often cited by papers focused on Heart Failure Treatment and Management (33 papers), Cardiovascular Function and Risk Factors (30 papers) and Cardiac pacing and defibrillation studies (14 papers). Alfonso Varela‐Román collaborates with scholars based in Spain, Italy and United States. Alfonso Varela‐Román's co-authors include José Ramón González‐Juanatey, Lilian Grigorian Shamagian, Inés Gómez‐Otero, Lilián Grigorian-Shamagian, Ezequiel Álvarez, Sergio Raposeiras‐Roubín, José Marı́a Garcı́a-Acuña, Bruno K. Rodiño‐Janeiro, Pilar Mazón Ramos and Juan F. Delgado and has published in prestigious journals such as European Heart Journal, The American Journal of Cardiology and American Heart Journal.

In The Last Decade

Alfonso Varela‐Román

64 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alfonso Varela‐Román Spain 21 911 151 125 118 93 67 1.2k
Natasha J. McIntyre United Kingdom 20 260 0.3× 110 0.7× 167 1.3× 67 0.6× 83 0.9× 33 975
Anita Banerjee United Kingdom 15 195 0.2× 74 0.5× 52 0.4× 141 1.2× 34 0.4× 58 838
Erwin H. Fleischmann Germany 14 280 0.3× 213 1.4× 34 0.3× 245 2.1× 172 1.8× 19 884
Vesna Degoricija Croatia 12 162 0.2× 74 0.5× 34 0.3× 93 0.8× 51 0.5× 50 452
Leszek Tylicki Poland 21 356 0.4× 237 1.6× 20 0.2× 227 1.9× 44 0.5× 86 1.2k
Auke H. Brantsma Netherlands 11 402 0.4× 243 1.6× 25 0.2× 146 1.2× 55 0.6× 11 1.0k
Matthew F. Yuyun United States 17 619 0.7× 321 2.1× 12 0.1× 99 0.8× 80 0.9× 45 1.2k
Simona Bruno Italy 8 476 0.5× 332 2.2× 34 0.3× 196 1.7× 36 0.4× 10 1.2k
Mats Bojestig Sweden 15 218 0.2× 512 3.4× 35 0.3× 180 1.5× 37 0.4× 19 979
Alessandra Chinaglia Italy 15 965 1.1× 63 0.4× 15 0.1× 254 2.2× 41 0.4× 41 1.1k

Countries citing papers authored by Alfonso Varela‐Román

Since Specialization
Citations

This map shows the geographic impact of Alfonso Varela‐Román's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alfonso Varela‐Román with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alfonso Varela‐Román more than expected).

Fields of papers citing papers by Alfonso Varela‐Román

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alfonso Varela‐Román. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alfonso Varela‐Román. The network helps show where Alfonso Varela‐Román may publish in the future.

Co-authorship network of co-authors of Alfonso Varela‐Román

This figure shows the co-authorship network connecting the top 25 collaborators of Alfonso Varela‐Román. A scholar is included among the top collaborators of Alfonso Varela‐Román based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alfonso Varela‐Román. Alfonso Varela‐Román is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cinza‐Sanjurjo, Sergio, Pilar Mazón‐Ramos, Inés Gómez‐Otero, et al.. (2025). Continuity of primary care and its impact on prognosis in patients with heart failure referred for cardiology consultation. BMC Primary Care. 26(1). 375–375.
2.
Barge‐Caballero, Gonzalo, Manuel J. López‐Pérez, Inés Gómez‐Otero, et al.. (2025). Transthyretin serum levels and clinical outcomes in patients with transthyretin amyloid cardiomyopathy. PubMed. 142. 106350–106350. 2 indexed citations
3.
Gómez‐Otero, Inés, et al.. (2024). Valor pronóstico de la razón desplazamiento sistólico del plano del anillo tricuspídeo/presión arterial pulmonar sistólica en la amiloidosis cardiaca. Revista Española de Cardiología. 77(8). 634–644. 1 indexed citations
4.
Barge‐Caballero, Gonzalo, Eduardo Barge‐Caballero, Manuel J. López‐Pérez, et al.. (2021). Beta-Blocker Exposure and Survival in Patients With Transthyretin Amyloid Cardiomyopathy. Mayo Clinic Proceedings. 97(2). 261–273. 20 indexed citations
5.
López‐Otero, Diego, Javier López‐País, Noelia Bouzas‐Cruz, et al.. (2020). Impact of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on COVID-19 in a western population. CARDIOVID registry. Revista Española de Cardiología (English Edition). 74(2). 175–182. 24 indexed citations
6.
López‐País, Javier, Diego López‐Otero, Alfonso Varela‐Román, et al.. (2020). Fast track triage for COVID-19 based on a population study: The soda score. Preventive Medicine Reports. 21. 101298–101298. 4 indexed citations
7.
Agra, Rosa M., Manuela Gago-Domínguez, Beatriz Paradela‐Dobarro, et al.. (2019). Obesity-Related Genetic Determinants of Heart Failure Prognosis. Cardiovascular Drugs and Therapy. 33(4). 415–424. 5 indexed citations
8.
Gómez‐Otero, Inés, et al.. (2018). P911Tolerability and safety of sacubitril/valsartan in high-risk subgroups. European Heart Journal. 39(suppl_1). 2 indexed citations
9.
Agra, Rosa M., Alfonso Varela‐Román, Rocío González-Ferreiro, et al.. (2016). Orosomucoid as prognosis factor associated with inflammation in acute or nutritional status in chronic heart failure. International Journal of Cardiology. 228. 488–494. 12 indexed citations
10.
Eirás, Sonia, Alfonso Varela‐Román, Mariléia Cháves Andrade, et al.. (2016). Non classical Monocytes Levels, Increased by Subcutaneous Fat-Secretome, Are Associated with Less Rehospitalization after Heart Failure Admission. Journal of Cardiovascular Translational Research. 10(1). 16–26. 7 indexed citations
11.
Crespo‐Leiro, María G., Javier Segovia, José González‐Costello, et al.. (2015). Adherence to the ESC Heart Failure Treatment Guidelines in Spain: ESC Heart Failure Long-term Registry. Revista Española de Cardiología (English Edition). 68(9). 785–793. 40 indexed citations
12.
Raposeiras‐Roubín, Sergio, Bruno K. Rodiño‐Janeiro, Lilián Grigorian-Shamagian, et al.. (2011). Evidence for a role of advanced glycation end products in atrial fibrillation. International Journal of Cardiology. 157(3). 397–402. 46 indexed citations
13.
Raposeiras‐Roubín, Sergio, Bruno K. Rodiño‐Janeiro, Lilián Grigorian-Shamagian, et al.. (2011). Productos de glicación avanzada: nuevo marcador de disfunción renal en pacientes con insuficiencia cardíaca crónica. Medicina Clínica. 136(12). 513–521. 1 indexed citations
14.
Raposeiras‐Roubín, Sergio, Bruno K. Rodiño‐Janeiro, Lilián Grigorian-Shamagian, et al.. (2010). Soluble Receptor of Advanced Glycation End Products Levels are Related to Ischaemic Aetiology and Extent of Coronary Disease in Chronic Heart Failure Patients, Independent of Advanced Glycation End Products Levels. European Journal of Heart Failure. 12(10). 1092–1100. 55 indexed citations
15.
Grigorian-Shamagian, Lilián, Emad Abu Assi, Rafael Vidal-Pérez, et al.. (2008). Why and when do patients with heart failure and normal left ventricular ejection fraction die? Analysis of >600 deaths in a community long-term study. American Heart Journal. 156(6). 1184–1190. 40 indexed citations
16.
Otero-Raviña, Fernando, et al.. (2007). Estudio gallego de insuficiencia cardiaca en atención primaria (estudio GALICAP). Revista Española de Cardiología. 60(4). 373–383. 21 indexed citations
17.
Varela‐Román, Alfonso, et al.. (2005). Influence of Diabetes on the sUrvival Of Patients Hospitalized with Heart Failure: A 12-Year Study. European Journal of Heart Failure. 7(5). 859–864. 52 indexed citations
18.
Shamagian, Lilian Grigorian, et al.. (2005). Atrial fibrillation in patients hospitalized for congestive heart failure: The same prognostic influence independently of left ventricular systolic function?. International Journal of Cardiology. 110(3). 366–372. 18 indexed citations
19.
González‐Juanatey, José Ramón, et al.. (2003). Long‐Term Improvement of QT Dispersion is Unaffected by Short‐Term Changes in Blood Pressure During Treatment of Systemic Hypertension with Enalapril. Annals of Noninvasive Electrocardiology. 8(1). 47–54. 3 indexed citations
20.
González‐Juanatey, José Ramón, Antonio Pose Reino, José Marı́a Garcı́a-Acuña, et al.. (1998). Effects on Left Ventricular Mass and Function of Low Doses of Enalapril for Systemic Hypertension. The American Journal of Cardiology. 81(1). 87–90. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026